NCT07528235: An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intravenous Pump-Delivered Propranolol in Patients With ICH

Sponsor: Tang-Du Hospital. Phase: PHASE1. Conditions: Intracerebral Hemorrhage, Stroke-Associated Pneumonia (SAP)